🚨 New publication from partner CNRS and colleagues: Inhibition of SUV39H1 as a potent therapeutic target in multiple myeloma.
Congratulations to the authors on this important contribution. 👏
https://t.co/VjKE9j7tX7
#MultipleMyeloma#CancerResearch#HorizonEU#EUfunding
How can digital innovation change the way Europe understands and treats cancer?
Join the EU Cancer Mission Conference in Nicosia on 27 April 2026 to explore data-driven projects and strategies to reduce inequalities in cancer care.
🔗https://t.co/KRGEw8mjjf
#MissionCancer
7th General Assembly Meeting
On 27–28 Jan, our consortium met in Cyprus to review progress and align on the final project phase.
Key advances in clinical data, omics & collaboration as we enter the final year.
#MultipleMyeloma#HorizonEU#ResearchInnovation#Collaboration
New paper from our colleagues at @NeuroGeneticsCy in IJMS: "Integrative network analysis of single-cell RNA identifies novel gene regulators in multiple myeloma".
📖 https://t.co/jVZMdAzlzD
👏 Congrats to the CING team!
#MultipleMyeloma#CancerResearch#HorizonEU#EUfunding
𝐋𝐚𝐮𝐧𝐜𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐥𝐨𝐧𝐚𝐥 𝐯𝐬. 𝐧𝐨𝐫𝐦𝐚𝐥 𝐂𝐃𝟏𝟑𝟖⁺ 𝐬𝐩𝐢𝐧-𝐨𝐟𝐟 𝐬𝐭𝐮𝐝𝐲
A new 𝐄𝐋𝐌𝐔𝐌𝐘 spin-off study is beginning, aiming to resolve a key challenge in plasma cell dyscrasias.
The original 𝐄𝐋𝐌𝐔𝐌𝐘 project set ambitious goals; completing such a large batch already exceeds expectations and moves the consortium ahead. This progress was made possible through the long-term vision and commitment of the Alexandra Hospital clinical team.
Excited to share our new Proteomics article: “Easy Proteomics Sample Preparation: Technical Repeatability & Workflow Optimization Across 8 Biological Matrices in a New Core Facility Setting". https://t.co/s8xLbgHl1t
#multiplemyeloma#missioncancer#HorizonEU#EUfunding
Exciting new study from our partners at NHRF that reveals how DNA damage response and redox imbalance shape apoptosis & sensitivity to genotoxic agents in multiple myeloma cells.
👉 https://t.co/UH2Dyu91oK
Congrats to all!
#MultipleMyeloma#MissionCancer#HorizonEU#EUfunding
Dr. Iryna Lishchuk, LL.M., from partner LUH, represented #ELMUMY at the L3S Retreat (7–9 Oct 2025) in Germany.
Iryna presented her poster “IT and Legal Data Sharing Solutions,” showcasing ELMUMY’s goals and insights on IT and legal issues.
#multiplemyeloma#HorizonEU#EUfunding